Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001576280-22-000092
Filing Date
2022-11-03
Accepted
2022-11-03 17:13:19
Documents
86
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gh-20220930.htm   iXBRL 10-Q 2235059
2 EX-31.1 gh-09302022x10qxex311.htm EX-31.1 10428
3 EX-31.2 gh-09302022x10qxex312.htm EX-31.2 10420
4 EX-31.3 gh-09302022x10qxex313.htm EX-31.3 10524
5 EX-32.1 gh-09302022x10qxex321.htm EX-32.1 6037
6 EX-32.2 gh-09302022x10qxex322.htm EX-32.2 6039
7 EX-32.3 gh-09302022x10qxex323.htm EX-32.3 6080
  Complete submission text file 0001576280-22-000092.txt   10948122

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20220930.xsd EX-101.SCH 63914
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gh-20220930_cal.xml EX-101.CAL 105578
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gh-20220930_def.xml EX-101.DEF 400827
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20220930_lab.xml EX-101.LAB 840377
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20220930_pre.xml EX-101.PRE 597946
80 EXTRACTED XBRL INSTANCE DOCUMENT gh-20220930_htm.xml XML 2080410
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38683 | Film No.: 221359104
SIC: 8071 Services-Medical Laboratories